- Home
- KEQU
as 02-21-2025 4:00pm EST
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
| Founded: | 1906 | Country: | United States |
| Employees: | N/A | City: | STATESVILLE |
| Market Cap: | 183.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 23.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 6.31 | EPS Growth: | 168.79 |
| 52 Week Low/High: | $27.00 - $71.33 | Next Earning Date: | 03-05-2025 |
| Revenue: | $199,637,000 | Revenue Growth: | -7.18% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Kewaunee Scientific Corporation (KEQU)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HULL THOMAS DAVID III | KEQU | President, CEO | Jan 10 '25 | Sell | $60.08 | 1,368 | $82,189.44 | 41,129 | |
| Gardner Donald T. III | KEQU | Chief Financial Officer | Jan 10 '25 | Sell | $59.26 | 1,257 | $74,489.82 | 21,358 | |
| Noble Ryan S. | KEQU | VP-Sales & Marketing-Americas | Dec 30 '24 | Sell | $66.00 | 1,500 | $99,000.00 | 11,823 | |
| Batdorff Douglas J. | KEQU | VP of Manufacturing Operations | Dec 30 '24 | Sell | $65.50 | 3,470 | $227,285.00 | 5,000 | |
| HULL THOMAS DAVID III | KEQU | President, CEO | Dec 26 '24 | Sell | $63.01 | 2,000 | $126,020.00 | 41,129 | |
| Gardner Donald T. III | KEQU | Chief Financial Officer | Dec 24 '24 | Sell | $59.65 | 2,049 | $119,236.62 | 21,358 | |
| Phillips Elizabeth D | KEQU | VP - Human Resources | Dec 17 '24 | Sell | $54.17 | 1,850 | $100,214.50 | 13,591 |
Latest Kewaunee Scientific Corporation News
KEQU Breaking Stock News: Dive into KEQU Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Kewaunee Scientific Corporation (NASDAQ:KEQU) has caught the attention of institutional investors who hold a sizeable 42% stake
Zacks
11 days ago
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
Simply Wall St.
20 days ago
Should You Be Adding Kewaunee Scientific (NASDAQ:KEQU) To Your Watchlist Today?
Zacks
a month ago
The Zacks Analyst Blog The Home Depot, RTX, Applied Materials, Kewaunee Scientific and AXIL Brands
Zacks
2 months ago
Kewaunee Scientific's Q2 Earnings Rise Y/Y Despite Sales Decline
PR Newswire
2 months ago
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
PR Newswire
3 months ago
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
TipRanks
4 months ago
Kewaunee Scientific Expands with Nu Aire Acquisition
Compare KEQU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KEQU Kewaunee Scientific Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.